The U.S. government has filed to withdraw certain medicines from the WTO’s Government Procurement Agreement rules in order to implement “Buy American” health care sourcing during the pandemic. Both the Trump and Biden administration’s have committed to sourcing locally and the move comes as U.S. imports of pharmaceutical categories including drugs needed to treat COVID-19 fell by 8.3% year over year in October. Supplies of PPE and diagnostics climbed by 83.2% and 40.2% respectively, though shipments are below their summer peaks. Imports of vaccines and immunolo...